Evaluation of the Functional Reserve and Exercise Tolerance in Patients with CHF in Clinical Trials (Consent Document of the Editorial board of the Journal of Cardiology, the Board of the Society of Specialists in Heart Failure (SSHF) and Working Group “Non-drug treatment methods” of SSHF)-Reference-Cited by-同舟云学术

Evaluation of the Functional Reserve and Exercise Tolerance in Patients with CHF in Clinical Trials (Consent Document of the Editorial board of the Journal of Cardiology, the Board of the Society of Specialists in Heart Failure (SSHF) and Working Group “Non-drug treatment methods” of SSHF)

Published:2024-07-31 Issue:7 Volume:64 Page:4-26
ISSN:2412-5660
Container-title:Kardiologiia
language:
Short-container-title:Kardiologiia

Author:

Begrambekova Yu. L.¹^ORCID,Arutynov G. P.²^ORCID,Glezer M. G.³^ORCID,Karanadze N. A.¹,Kolesnikova E. A.²,Lelyavina T. A.⁴,Lishuta A. S.⁵^ORCID,Orlova Ya. A.¹^ORCID,Belenkov Yu. N.⁵^ORCID

Affiliation:

1. Medical Research and Educational Center, Lomonosov Moscow State University

2. Pirogov Russian National Research Medical University

3. Vladimirsky Moscow Regional Research Clinical Institute; Sechenov First Moscow State Medical University

4. Almazov National Medical Research Center

5. Sechenov First Moscow State Medical University

Abstract

Assessing the functional capacity and exercise tolerance is an important and widely used research tool in patients with heart failure. It is used not only in cardiac rehabilitation and physical therapy, but also for inclusion criteria and outcome measures in studies of drug interventions. This document outlines the scope, guidelines for the implementation and interpretation, and limitations of the methods for assessing the functional capacity and exercise tolerance in clinical trials in patients with heart failure.

Publisher

APO Society of Specialists in Heart Failure

Reference97 articles.

1. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 9th ed. P. 253-256. Dolgin M, New York Heart Association, editors - Boston, Mass.: Little, Brown and Co, 1994. – 334p. ISBN 978-0-316-60538-0

2. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation. 1981;64(6):1227–34. DOI: 10.1161/01.CIR.64.6.1227

3. Raphael C, Briscoe C, Davies J, Ian Whinnett Z, Manisty C, Sutton R et al. Limitations of the New York Heart Association functional classification system and self-reported walking distances in chronic heart failure. Heart. 2007;93(4):476–82. DOI: 10.1136/hrt.2006.089656

4. Yap J, Lim FY, Gao F, Teo LL, Lam CSP, Yeo KK. Correlation of the New York Heart Association Classification and the 6‐Minute Walk Distance: A Systematic Review. Clinical Cardiology. 2015;38(10):621–8. DOI: 10.1002/clc.22468

5. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM. Two- , six-, and 12-minute walking tests in respiratory disease. BMJ. 1982;284(6329):1607–8. DOI: 10.1136/bmj.284.6329.1607